2m 2m 2m 2m 2m 2m 2m
SILO PHARMA (SILO)
NASDAQ
$4.15-$0.05 (-1.07%)
Price as of Aug 03, 2026 7:19 AM EDT- $4.7MMarket Cap
- -61.53%1-Year Change
- BiotechnologyIndustry
SILO PHARMA (SILO)
$4.15-$0.05 (-1.07%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 72,102 0.00% | 72,102 0.00% | 72,102 -0.74% | 72,637 -70.78% | |
Cost of Revenue | 44,295 +658.74% | 5,838 0.00% | 5,838 0.00% | 5,838 +16.67% | |
Gross Profit | 27,807 -58.04% | 66,264 0.00% | 66,264 0.00% | 66,264 +0.006% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | 390,071 +71.64% | 227,259 +39.46% | |
Research and Development Expense | -2.2M -8.75% | -2.4M +180.22% | -845,092 -34.31% | -1.3M +85.39% | |
Depreciation and Amortization Expense | 11,440 +84.96% | 6,185 N/A | N/A N/A | N/A N/A | |
Total Operating Expenses | 4.3M -9.71% | 4.8M +21.68% | 3.9M +6.17% | 3.7M +31.43% | |
Operating Profit | -4.3M -9.03% | -4.7M +22.05% | -3.9M +6.28% | -3.6M +32.19% | |
Interest Income | 193,912 -41.80% | 333,165 -16.40% | 398,530 +448.66% | 72,637 +5,903.06% | |
Interest Expense | N/A N/A | N/A N/A | -4,869 +121.42% | -2,199 -27.57% | |
Interest Income and Expense and Net | 193,912 -41.80% | 333,165 -15.37% | 393,661 +458.88% | 70,438 +3,957.50% | |
Total Nonoperating Income and Expense | 52,964 -83.07% | 312,814 +39.33% | 224,509 +180.26% | -279,732 -104.04% | |
Income before Taxes | -4.2M -3.76% | -4.4M +20.98% | -3.6M -7.07% | -3.9M -193.43% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Extraordinary Items | 39,916 N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -4.2M -3.76% | -4.4M +18.70% | -3.7M -5.32% | -3.9M -200.12% | |
Net Income from Continuing Operations Applicable to Common | -4.2M -3.76% | -4.4M +20.98% | -3.6M -7.07% | -3.9M -193.99% | |
Basic EPS and Net Income | -0.50 -57.98% | -1.19 N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -0.50 -57.98% | -1.19 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 8.4M +127.76% | 3.7M +19.50% | 3.1M +34.83% | 2.3M -97.59% | |
Diluted Weighted Average Shares | 8.4M +127.76% | 3.7M +19.50% | 3.1M +34.83% | 2.3M -97.62% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.7M +21.58% | 3.9M +10.82% | 3.5M -69.00% | 11.4M +15.55% | |
Short-Term Investments | 2.1M -33.54% | 3.2M -23.33% | 4.1M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 6.9M -3.13% | 7.1M -7.63% | 7.7M -32.57% | 11.4M +15.55% | |
Total Current Assets | 7.4M +3.88% | 7.1M -7.42% | 7.7M -33.62% | 11.6M +11.24% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Assets | 217,375 -27.63% | 300,360 N/A | N/A N/A | 481,898 +687.29% | |
Total Assets | 7.6M +2.61% | 7.4M -4.32% | 7.7M -33.47% | 11.6M +10.99% | |
Income Taxes Payable | N/A N/A | N/A N/A | 143,607 N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 364,216 +405.14% | |
Total Current Liabilities | 650,183 -60.74% | 1.7M +113.51% | 775,590 +77.76% | 436,318 -10.96% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 42,000 -33.37% | |
Total Long-Term Liabilities | 649,476 -9.99% | 721,578 -9.08% | 793,680 -8.33% | 865,782 -7.69% | |
Total Liabilities | 1.3M -45.34% | 2.4M +51.51% | 1.6M +20.52% | 1.3M -8.81% | |
Retained Earnings | -19.5M +27.70% | -15.3M +40.41% | -10.9M +51.61% | -7.2M +119.80% | |
Total Stockholders Equity | 6.3M +25.25% | 5.0M -18.50% | 6.2M -40.27% | 10.3M +14.11% | |
Total Shares Outstanding | 13.3M +196.99% | 4.5M +54.30% | 2.9M -8.00% | 3.2M -96.80% | |
Cash Flow | |||||
Cash from Operating Activities | -4.7M +21.58% | -3.8M +18.90% | -3.2M -7.81% | -3.5M +53.54% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 644,021 -33.86% | 973,777 +123.48% | -4.1M -4,882.90% | 86,707 -98.79% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 4.9M +49.93% | 3.2M +788.07% | -471,121 -109.54% | 4.9M +30.23% | |
Financials Ratio | |||||
Gross Margin | 38.57% -58.04% | 91.90% 0.00% | 91.90% -0.06% | 91.96% -6.15% | |
Operating Margin | -5,936.95% -9.03% | -6,526.44% +22.05% | -5,347.41% +7.07% | -4,994.23% +352.39% | |
Return on Assets | -56.31% -2.86% | -57.96% +51.84% | -38.17% +8.08% | -35.32% -153.91% | |
Return on Equity | -74.56% -4.85% | -78.37% +74.89% | -44.81% +11.22% | -40.29% -153.37% | |
Revenue Growth | 0.00% N/A | 0.00% +100.00% | -0.74% -98.96% | -70.78% -113.95% | |
Current Ratio | 11.36 +164.59% | 4.29 -56.64% | 9.90 -62.66% | 26.52 +24.94% | |
Cash Ratio | 7.30 +209.66% | 2.36 -48.09% | 4.54 -82.56% | 26.05 +29.78% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.04 +163.76% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.03 +170.54% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow